x

Search for a research project

* (*) mandatory field

70 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

WIEN
WIEN

Chromosome structure and antisense transcription in leukemia
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

AUSTRIA

STEIERMARK
GRAZ

The role of RKIP in myeloid leukemogenesis
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

AUSTRIA

STEIERMARK
GRAZ

Subclonal TP53 mutations in acute myeloid leukemia
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

Charting and Disrupting the Gene-Regulatory Function of CDK6
AKH BT 25.3
Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Functional interactions between EVI1 and atRA in leukemic stem cells
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

AUSTRIA

WIEN
WIEN

Find tumor immune evasion strategies by cellular barcoding
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Linking CDK6 to the epigenome in AML (acute myeloid leukemia)
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberONCOMECHAML: Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia - AT
Veterinärmedizinische Universität Wien
Institut für Medizinische Biochemie

CANADA

Ontario
TORONTO

Funded by an IRDiRC memberCD123-Targeted Auger Electron Radioimmunotherapy of Acute Myelogenous Leukemia (AML)
University of Toronto
Leslie Dan Faculty of Pharmacy, University of Toronto

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

GERMANY

Baden-Württemberg
MANNHEIM

GERMANY

Baden-Württemberg
ULM

Evaluation of Incidence and Prognostic Importance of Gene Mutations in acute myeloid leukemia (AML)
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

GERMANY

Baden-Württemberg
ULM

Design and Evaluation of Real-Time RT-PCR Assays for the Detection of Minimal Residual Disease in AML
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

GERMANY

Baden-Württemberg
ULM

GERMANY

Hessen
MARBURG

A synthetic lethal screen to identify novel targets for therapy in acute myeloid leukemia
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Hessen
MARBURG

Epigenetics of the nuclear oncogene Ski in AML (SPP 1463: Epigenetic regulation of normal hematopoiesis and its dysregulation in myeloid neoplasia)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Hessen
MARBURG

Cooperation of Ras induced signaling and the nuclear oncogene Ski in acute myeloid leukemia (AML) and malignant melanoma (TRR 17: Ras-dependent pathways in human cancer)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Niedersachsen
HANNOVER

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
KPOH Geschäftsführung Hannover
Kompetenznetz Pädiatrische Onkologie und Hämatologie

GERMANY

Niedersachsen
HANNOVER

The histamine H2-receptor as new target for differentiation therapy in acute myeloic leukemia
Medizinische Hochschule Hannover
Institut für Pharmakologie

GERMANY

Nordrhein-Westfalen
ESSEN

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

GERMANY

Sachsen
DRESDEN

AML Registry: Clinical AML Registry
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I

SPAIN

Andalucía
CÓRDOBA

Funded by an IRDiRC memberImplications of immunosenescence in the design of antitumor immunotherapy protocols based on NK cells in melanoma and acute myeloid leukemia models
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba
GC01 T and NK cell Immunosenescence Antiviral Immune Response

SPAIN

Cataluña
BARCELONA

Funded by an IRDiRC memberClonal heterogeneity in acute myeloid leukemia: immunophenotypic and genotypic characterization and by generation of xenografts
IIB Sant Pau - Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Grupo de investigación clínica en oncología

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Comunidad Valenciana
VALENCIA

Funded by an IRDiRC memberTracking and validation of mutations in the non-coding regions and spliceosome genes in acute myeloblastic leukemia (AML)
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en hematología y hemoterapia

SWEDEN

Stockholms läns landsting
HUDDINGE

Molecular pathogenesis in myelodysplastic syndromes and acute myeloid leukemia
Karolinska Institutet - Huddinge
Department of Medicine

SWEDEN

Stockholms läns landsting
STOCKHOLM

Study of chemotherapy resistance and DNA methylation in acute myeloid leukemia samples
Karolinska Universitetssjukhuset - Huddinge
Hematology Centre

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberTherapeutics for rare and neglected diseases - science
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberMechanistic and translational studies of cbf leukemia
Institution: Information not provided - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberMolecular pathogenesis of chromosome 16 inversion in human leukemia
Institution: Information not provided - US

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANY

Baden-Württemberg
HEIDELBERG

Funded by an IRDiRC memberERA-NET TRANSCAN: TORPEDO - Targeting Of Resistance in PEDiatric Oncology (coordination)
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ITALY

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Multicentric Research projects